Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q5H8A4
UPID:
PIGG_HUMAN
Alternative names:
GPI7 homolog; Phosphatidylinositol-glycan biosynthesis class G protein
Alternative UPACC:
Q5H8A4; B4DKC7; Q2TAK5; Q6UX31; Q7L5Y4; Q8N866; Q8NCC9; Q96SY9; Q9BVT7; Q9NXG5
Background:
GPI ethanolamine phosphate transferase 2, also known as GPI7 homolog and Phosphatidylinositol-glycan biosynthesis class G protein, plays a crucial role in glycosylphosphatidylinositol-anchor biosynthesis. This process is essential for attaching certain proteins to the cell membrane, facilitating cell-to-cell communication and signal transduction.
Therapeutic significance:
The protein is linked to a neurodevelopmental disorder characterized by delayed psychomotor development, hypotonia, seizures, and possible cerebellar atrophy. Understanding the role of GPI ethanolamine phosphate transferase 2 could open doors to potential therapeutic strategies for this disorder.